WHO ICTRP trial
Randomized, controlled, open label clinical study on the pharmacokinetic…
ChiCTR2500101210 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500101210 |
|---|---|
| Public title | Randomized, controlled, open label clinical study on the pharmacokinetic interaction between montmorillonite powder and apatinib mesylate tablets in human |
| Scientific title | Randomized, controlled, open label clinical study on the pharmacokinetic interaction between montmorillonite powder and apatinib mesylate tablets in human |
| Primary sponsor | Changzhou Cancer (Fourth People's) Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Malignant tumor |
| Interventions | Control group:About 50 ml Wahaha purified water;Experimental group 1 (simultaneous medication):Simultaneously using montmorillonite powder;Experimental group 2 (interval medication):Interval use of montmorillonite powder |
| Registration date | Apr 22, 2025 |
| Target size | Control group:6;Experimental group 1 (simultaneous medication):6;Experimental… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: